KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elanco Animal Health (ELAN) Net Margin (2017 - 2025)

Elanco Animal Health's Net Margin history spans 9 years, with the latest figure at 24.13% for Q4 2025.

  • For Q4 2025, Net Margin fell 2334.0% year-over-year to 24.13%; the TTM value through Dec 2025 reached 4.92%, down 1253.0%, while the annual FY2025 figure was 4.92%, 1253.0% down from the prior year.
  • Net Margin for Q4 2025 was 24.13% at Elanco Animal Health, down from 2.99% in the prior quarter.
  • Across five years, Net Margin topped out at 35.34% in Q3 2024 and bottomed at 102.62% in Q3 2023.
  • The 5-year median for Net Margin is 4.45% (2022), against an average of 7.69%.
  • The largest annual shift saw Net Margin plummeted -9629bps in 2023 before it soared 13796bps in 2024.
  • A 5-year view of Net Margin shows it stood at 9.26% in 2021, then surged by 50bps to 4.67% in 2022, then plummeted by -192bps to 13.62% in 2023, then soared by 94bps to 0.78% in 2024, then plummeted by -2976bps to 24.13% in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Net Margin are 24.13% (Q4 2025), 2.99% (Q3 2025), and 0.89% (Q2 2025).